InvestorsHub Logo
Followers 864
Posts 27574
Boards Moderated 1
Alias Born 11/05/2010

Re: PoemStone post# 348

Thursday, 10/11/2012 7:47:17 AM

Thursday, October 11, 2012 7:47:17 AM

Post# of 564
KYTHERA Biopharmaceuticals Announces Pricing of Initial Public Offering
http://finance.yahoo.com/news/kythera-biopharmaceuticals-announces-pricing-initial-110000848.html

LOS ANGELES--(BUSINESS WIRE)--

KYTHERA Biopharmaceuticals, Inc. (“KYTHERA”) today announced the pricing of its initial public offering of 4,400,000 shares of its common stock at a price to the public of $16.00 per share. The shares of KYTHERA's common stock will trade on the NASDAQ Global Select Market under the symbol "KYTH." All of the shares of common stock are being offered by KYTHERA. In addition, KYTHERA has granted the underwriters a 30-day option to purchase up to an additional 660,000 shares of common stock to cover over-allotments, if any.

The offering is expected to close on October 16, 2012, subject to customary closing conditions.

J.P. Morgan Securities LLC and Goldman, Sachs & Co. are acting as joint book-running managers for the offering. Leerink Swann LLC is acting as lead co-manager and Lazard Capital Markets LLC is acting as co-manager.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on October 10, 2012. Copies of the registration statement, as amended, can be accessed through the SEC's website at www.sec.gov.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.